Ray Therapeutics, Inc.

Our CEO Paul Bresge speaks with Raising Biotech podcast host Surani Fernando about leveraging #optogenetics to tackle #vision loss. Surani is also joined by renowned optogenetics leader Dr. José-Alain Sahel, Distinguished Professor, Department of Ophthalmology, University of Pittsburgh School of Medicine, to talk about Ray's scientific foundations, early data, theoretical safety/efficacy profile and potential to make a meaningful impact in late-stage retinal disorder patients with close to no vision. Listen to the discussion: 👇👇 https://lnkd.in/efGwJP36

Our CEO Paul Bresge speaks with Raising Biotech podcast host Surani Fernando about leveraging #optogenetics to tackle #vision loss. Surani is also joined by renowned optogenetics leader Dr. José-Alain Sahel, Distinguished Professor, Department of Ophthalmology, University of Pittsburgh School of Medicine, to talk about Ray's scientific foundations, early data, theoretical safety/efficacy profile and potential to make a meaningful impact in late-stage retinal disorder patients with close to no vision. Listen to the discussion: 👇👇 https://lnkd.in/efGwJP36

We are hiring! https://lnkd.in/gBwPFJRW

Join us on Saturday, May 4th at the Four Seasons Hotel Seattle for the "𝗦𝗽𝗼𝘁𝗹𝗶𝗴𝗵𝘁 𝗼𝗻 𝗥𝗲𝗴𝗲𝗻𝗲𝗿𝗮𝘁𝗶𝘃𝗲 𝗠𝗲𝗱𝗶𝗰𝗶𝗻𝗲" moderated by world-renowned expert Dr. Mark Humayun. This session will delve into groundbreaking advancements and innovative approaches in vision restoration with highly esteemed speakers Sulagna Bhattacharya, Peter Francis, MD PhD, Ram Palanki, John Pollack, MD, and Matthias Steger PhD, MBA. Don't miss your chance to gain strategic insights and network with key players in the field. https://lnkd.in/geVddkw4 USC Roski Eye Institute Nanoscope Therapeutics Inc. Ray Therapeutics, Inc. REGENXBIO Inc. jCyte, Inc. Endogena Therapeutics, Inc. #OIS #OISRetina #OISRetina2024 #Ophthalmology #Innovation #RoskiEyeInstitute #Nanoscope #RayTherapeutics #REGENXBIO #jCyte #Endogena #SulagnaBhattacharya #PeterFrancis #RamPalanki #JohnPollack #MatthiasSteger

𝐄𝐱𝐜𝐢𝐭𝐢𝐧𝐠 𝐧𝐞𝐰𝐬! The lineup of 𝐩𝐫𝐞𝐬𝐞𝐧𝐭𝐢𝐧𝐠 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 for the OIS Retina Innovation Summit is here! Don't miss out on the chance to witness cutting-edge developments in retinal health and technology. 𝐑𝐞𝐬𝐞𝐫𝐯𝐞 𝐲𝐨𝐮𝐫 𝐬𝐩𝐨𝐭 𝐭𝐨𝐝𝐚𝐲 before tickets run out! https://lnkd.in/ecAcYeV4 Annexin Pharmaceuticals AB (publ), Annexon Biosciences, Eluminex Biosciences Limited, Endogena Therapeutics, Inc., EyePoint Pharmaceuticals, FELIQS, ForwardVue Pharma, GelMEDIX, InflammX Therapeutics, Isarna Therapeutics GmbH, jCyte, Inc., Kiora Pharmaceuticals, Inc., Kriya, Nanoscope Therapeutics Inc., Neurotech Pharmaceuticals, Inc., Ocular Therapeutix, Inc., Oculis, ONL Therapeutics, Optigo Biotherapeutics, Outlook Therapeutics, Inc., RevOpsis Therapeutics, Ray Therapeutics, Inc., REGENXBIO Inc., Retinai, Ripple Therapeutics  , Stealth BioTherapeutics, Stuart Therapeutics, Tarsier Pharma #OIS #OISRetina #Ophthalmology #Innovation #Retina #Annexin #Annexon #Eluminex #Endogena #EyePoint #FELIQS #ForwardVue #GelMEDIX #InflammX #Isarna #jCyte #Kiora #Kriya #Nanoscope #Neurotech #OcularTherapeutix #Oculis #ONLTherapeutics #OptigoBiotherapeutics #OutlookTherapeutics #RevOpsis #RayTherapeutics #REGENXBIO #Retinai #RippleTherapeutics #StealthBioTherapeutics #StuartTherapeutics #TarsierPharma

RayTx is looking for a Accounting/Bookeeping Supervisor. Go to our website for more information: https://lnkd.in/ge32XrUi

📣 Next week! Register for our can’t-miss webinar with leading gene therapy experts! Join us for an engaging webinar with Endpoints News, where industry leaders David Dismuke, Jenny Holt, Karen Kozarsky, Ph.D., and John Maslowski will examine the essential "7 questions gene therapy developers should ask their CDMO (and what they will ask you!)" We will explore crucial topics like yield, commercial readiness, validated scale-down models, automation of analytical assays, and more. Register here ➡️ https://bit.ly/3SMK31W

This week's podcast features industry leaders including our CEO Paul Bresge sharing valuable insights on early commercial strategy and navigating the journey from regulatory approval to commercialization. This #OISXIII panel is a must-listen for anyone in the industry! Listen here: 👇👇 https://lnkd.in/gzi9nzJ3

Join our CEO Paul Bresge at the upcoming #JPM24 #BiotechShowcase conference on Jan 10th at 8 am PT: "The Shifting Tide from Rare to Chronic Disease." He's joined by an esteemed panel including: Kenneth Moch, President, Euclidean Life Science Advisors Jack O'Meara, CEO, Ochre Bio Regina Salvat, Principal, Sofinnova Investments Michael Margolis, Co-Head of Healthcare Investment Banking, Oppenheimer & Co. Inc. Nigel Sheail, Venture Partner, Versant Ventures Hope to see you all there!

💡Featured Session- Advancements and Challenges in Cell & Gene Therapy Manufacturing💡 Register today to hear what these individuals have to say on Cell & Gene Therapy Manufacturing. Join over 500 senior #biotech and #pharma executives at Fierce JPM Week in San Francisco on Jan 9-10 as we delve further into this topic. Register now limited passes are left. https://lnkd.in/eTsmh7Pc ⭐ SPEAKERS INCLUDE⭐ ✅ Jenny Holt, Ray Therapeutics, Inc. ✅ Christopher McDonald, Kite Pharma, A Gilead Company ✅Morten Sogaard, Astellas Gene Therapies ✅ Brian Riley, Beam Therapeutics #WeAreFierce #FierceBiotech #FiercePharma #FierceJPMWeek #JPMWeek #Pharma #Biotech #jpmorganhealthcareconference